Table of content for "Ciltacabtagene car pos t" (HCPCS C9098)
General information on the “C9098” code
HCPCS Code: C9098
Long Description: Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Short Description: Ciltacabtagene car pos t
Original information is taken from C9098 page
Pricing indicators
Pricing Indicator Code 1: 53 – Statute
Multiple Pricing Indicator Code A : Not applicable as HCPCS priced under one methodology
Certification and additional reference information
Coverage
Coverage: C – Carrier judgment
Type of service
Berenson-Eggers Type of Service (BETOS): O1D – Chemotherapy
Type Of Service 1: 1 – Medical care
Misc information
Anesthesia Base Unit Quantity: 0
Code Added Date: 20220701
Code Effective Date: 20221001
Termination Date: 20220930
Action Code: N – No maintenance for this code